Artículos de revistas sobre el tema "Antibody-toxin conjugates"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Antibody-toxin conjugates".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Esteva, Francisco J., Kathy D. Miller y Beverly A. Teicher. "What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?" American Society of Clinical Oncology Educational Book, n.º 35 (mayo de 2015): e117-e125. http://dx.doi.org/10.14694/edbook_am.2015.35.e117.
Texto completoAhmad, Ateeq y Kevin Law. "Strategies for designing antibody-toxin conjugates". Trends in Biotechnology 6, n.º 10 (octubre de 1988): 246–51. http://dx.doi.org/10.1016/0167-7799(88)90056-x.
Texto completoGovindan, Serengulam V. y David M. Goldenberg. "New Antibody Conjugates in Cancer Therapy". Scientific World JOURNAL 10 (2010): 2070–89. http://dx.doi.org/10.1100/tsw.2010.191.
Texto completoLiang, X. P., M. E. Lamm y J. G. Nedrud. "Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus." Journal of Immunology 141, n.º 5 (1 de septiembre de 1988): 1495–501. http://dx.doi.org/10.4049/jimmunol.141.5.1495.
Texto completoPanjideh, Hossein, Nicole Niesler, Alexander Weng y Hendrik Fuchs. "Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861". Toxins 14, n.º 7 (13 de julio de 2022): 478. http://dx.doi.org/10.3390/toxins14070478.
Texto completoFaria, Morse, Marlking Peay, Brandon Lam, Eric Ma, Moucun Yuan, Michael Waldron, William Mylott, Meina Liang y Anton Rosenbaum. "Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2". Antibodies 8, n.º 1 (11 de enero de 2019): 11. http://dx.doi.org/10.3390/antib8010011.
Texto completoYu, Rui, Junjie Xu, Tao Hu y Wei Chen. "The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity". Mediators of Inflammation 2020 (4 de julio de 2020): 1–11. http://dx.doi.org/10.1155/2020/9596129.
Texto completoMarsh, J. W. y D. M. Neville. "A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxins." Journal of Immunology 140, n.º 10 (15 de mayo de 1988): 3674–78. http://dx.doi.org/10.4049/jimmunol.140.10.3674.
Texto completoGovindan, Serengulam V., Gary L. Griffiths, Hans J. Hansen, Ivan D. Horak y David M. Goldenberg. "Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies". Technology in Cancer Research & Treatment 4, n.º 4 (agosto de 2005): 375–91. http://dx.doi.org/10.1177/153303460500400406.
Texto completoLefeber, Dirk J., Barry Benaissa-Trouw, Johannes F. G. Vliegenthart, Johannis P. Kamerling, Wouter T. M. Jansen, Kees Kraaijeveld y Harm Snippe. "Th1-Directing Adjuvants Increase the Immunogenicity of Oligosaccharide-Protein Conjugate Vaccines Related to Streptococcus pneumoniae Type 3". Infection and Immunity 71, n.º 12 (diciembre de 2003): 6915–20. http://dx.doi.org/10.1128/iai.71.12.6915-6920.2003.
Texto completoMesserschmidt, Katrin y Katja Heilmann. "Toxin–antigen conjugates as selection tools for antibody producing cells". Journal of Immunological Methods 387, n.º 1-2 (enero de 2013): 167–72. http://dx.doi.org/10.1016/j.jim.2012.10.010.
Texto completoARNDT, R. y H. J. THIESEN. "Elimination of Trinitrophenol-Specific Antibody Response by Antigen-Toxin Conjugates". Scandinavian Journal of Immunology 22, n.º 5 (noviembre de 1985): 489–94. http://dx.doi.org/10.1111/j.1365-3083.1985.tb01907.x.
Texto completoOu, Li, Krishana Gulla, Andrea Biju, Daniel W. Biner, Tatsiana Bylund, Anita Changela, Steven J. Chen et al. "Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1". Vaccines 10, n.º 11 (12 de noviembre de 2022): 1916. http://dx.doi.org/10.3390/vaccines10111916.
Texto completoJohansson, Eva-Liz, Carola Rask, Margareta Fredriksson, Kristina Eriksson, Cecil Czerkinsky y Jan Holmgren. "Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates". Infection and Immunity 66, n.º 2 (1 de febrero de 1998): 514–20. http://dx.doi.org/10.1128/iai.66.2.514-520.1998.
Texto completoChen, Zhaochun, Rachel Schneerson, Julie A. Lovchik, Zhongdong Dai, Joanna Kubler-Kielb, Liane Agulto, Stephen H. Leppla y Robert H. Purcell. "Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax". Clinical and Vaccine Immunology 22, n.º 8 (3 de junio de 2015): 902–8. http://dx.doi.org/10.1128/cvi.00137-15.
Texto completoTrad, Ahmad, Hinrich P. Hansen, Mohammad Shomali, Matthias Peipp, Katja Klausz, Nina Hedemann, Kosuke Yamamoto et al. "ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates". Cancer Immunology, Immunotherapy 62, n.º 3 (1 de septiembre de 2012): 411–21. http://dx.doi.org/10.1007/s00262-012-1346-x.
Texto completoBergquist, C., T. Lagergård, M. Lindblad y J. Holmgren. "Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates." Infection and immunity 63, n.º 5 (1995): 2021–25. http://dx.doi.org/10.1128/iai.63.5.2021-2025.1995.
Texto completoSellrie, F. y B. Micheel. "Selection of recombinant antibody-producing E. coli cells by means of toxin conjugates". Biochemical Engineering Journal 38, n.º 3 (marzo de 2008): 309–13. http://dx.doi.org/10.1016/j.bej.2007.07.017.
Texto completoTedder, T. F., V. S. Goldmacher, J. M. Lambert y S. F. Schlossman. "Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system." Journal of Immunology 137, n.º 4 (15 de agosto de 1986): 1387–91. http://dx.doi.org/10.4049/jimmunol.137.4.1387.
Texto completoPrice, Gregory A., Michael W. Russell y Cynthia Nau Cornelissen. "Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice". Infection and Immunity 73, n.º 7 (julio de 2005): 3945–53. http://dx.doi.org/10.1128/iai.73.7.3945-3953.2005.
Texto completoSpeirs, Joan I. y Mumtaz Akhtar. "Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays". Canadian Journal of Microbiology 37, n.º 8 (1 de agosto de 1991): 650–53. http://dx.doi.org/10.1139/m91-110.
Texto completoSeong, Seung-Yong, Nam-Hyuk Cho, Ick Chan Kwon y Seo Young Jeong. "Protective Immunity of Microsphere-Based Mucosal Vaccines against Lethal Intranasal Challenge withStreptococcus pneumoniae". Infection and Immunity 67, n.º 7 (1 de julio de 1999): 3587–92. http://dx.doi.org/10.1128/iai.67.7.3587-3592.1999.
Texto completoPolito, Letizia, Giulia Calafato, Massimo Bortolotti, Cecilia Chiarelli Olivari, Stefania Maiello y Andrea Bolognesi. "Antibody Conjugates for Sarcoma Therapy: How Far along Are We?" Biomedicines 9, n.º 8 (8 de agosto de 2021): 978. http://dx.doi.org/10.3390/biomedicines9080978.
Texto completoKarsten, Lennard, Nils Janson, Vadim Le Joncour, Sarfaraz Alam, Benjamin Müller, Jayendrakishore Tanjore Ramanathan, Pirjo Laakkonen, Norbert Sewald y Kristian M. Müller. "Bivalent EGFR-Targeting DARPin-MMAE Conjugates". International Journal of Molecular Sciences 23, n.º 5 (23 de febrero de 2022): 2468. http://dx.doi.org/10.3390/ijms23052468.
Texto completoPeeters, C. C., A. M. Tenbergen-Meekes, C. J. Heijnen, J. T. Poolman, B. J. Zegers y G. T. Rijkers. "In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate." Journal of Immunology 147, n.º 12 (15 de diciembre de 1991): 4192–99. http://dx.doi.org/10.4049/jimmunol.147.12.4192.
Texto completoLu, Ying-Jie, Sophie Forte, Claudette M. Thompson, Porter W. Anderson y Richard Malley. "Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide". Infection and Immunity 77, n.º 5 (2 de marzo de 2009): 2076–83. http://dx.doi.org/10.1128/iai.01554-08.
Texto completoSenter, Peter D., Marilyn J. Tansey, John M. Lambert y Walter A. Blattler. "NOVEL PHOTOCLEAVABLE PROTEIN CROSSLINKING REAGENTS AND THEIR USE IN THE PREPARATION OF ANTIBODY-TOXIN CONJUGATES". Photochemistry and Photobiology 42, n.º 3 (septiembre de 1985): 231–37. http://dx.doi.org/10.1111/j.1751-1097.1985.tb08936.x.
Texto completoLiu, Yongheng, Wei Lian, Xi Zhao, Wei Qi, Jian Xu, Liang Xiao, Yan Qing, Tongtong Xue y Jingyi Wang. "A phase I study of safety and pharmacokinetics of A166, a novel selective inhibitor of human epidermal growth factor receptor-2 in Chinese patients with advanced solid tumors." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e13007-e13007. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13007.
Texto completoDardevet, Lucie, Feten Najlaoui, Sonia Aroui, Mayeul Collot, Céline Tisseyre, Michael W. Pennington, Jean-Maurice Mallet y Michel De Waard. "A Conjugate between Lqh-8/6, a Natural Peptide Analogue of Chlorotoxin, and Doxorubicin Efficiently Induces Glioma Cell Death". Biomedicines 10, n.º 10 (17 de octubre de 2022): 2605. http://dx.doi.org/10.3390/biomedicines10102605.
Texto completoPalanca-Wessels, Maria Corinna y Oliver W. Press. "Advances in the treatment of hematologic malignancies using immunoconjugates". Blood 123, n.º 15 (10 de abril de 2014): 2293–301. http://dx.doi.org/10.1182/blood-2013-10-492223.
Texto completoHammond, Philip W., Omid Vafa, Jonathan Jacinto, Jost Vielmetter, Sher Karki, Sean Yoder, Greg Lazar et al. "A Humanized Anti-CD30 Monoclonal Antibody, XmAb™2513, with Enhanced In Vitro Potency Against CD30-Positive Lymphomas Mediated by High Affinity Fc-Receptor Binding." Blood 106, n.º 11 (16 de noviembre de 2005): 1470. http://dx.doi.org/10.1182/blood.v106.11.1470.1470.
Texto completoPorath, Kendra A., Ann Mladek, Rachael A. Vaubel, Michael S. Regan, Sonia Jain, Danielle Burgenske, Katrina Bakken et al. "Abstract 334: Convection enhanced delivery of EGFR-targeting antibody drug conjugates ABBV-321 and Depatux-M". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 334. http://dx.doi.org/10.1158/1538-7445.am2022-334.
Texto completoAmbrosino, D. M., D. Bolon, H. Collard, R. Van Etten, M. V. Kanchana y R. W. Finberg. "Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages." Journal of Immunology 149, n.º 12 (15 de diciembre de 1992): 3978–83. http://dx.doi.org/10.4049/jimmunol.149.12.3978.
Texto completoDelprino, Laura, Maria Giacomotti, Franco Dosio, Paola Brusa, Maurizio Ceruti, Giorgio Grosa y Luigi Cattel. "Toxin-Targeted Design for Anticancer Therapy. II: Preparation and Biological Comparison of Different Chemically Linked Gelonin-Antibody Conjugates". Journal of Pharmaceutical Sciences 82, n.º 7 (julio de 1993): 699–704. http://dx.doi.org/10.1002/jps.2600820706.
Texto completoHamamichi, Shusei, Takeshi Fukuhara y Nobutaka Hattori. "Immunotoxin Screening System: A Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities". Toxins 12, n.º 10 (15 de octubre de 2020): 658. http://dx.doi.org/10.3390/toxins12100658.
Texto completoRiedl, Thilo, Egon van Boxtel, Martijn Bosch, Paul W. H. I. Parren y Arnout F. Gerritsen. "High-Throughput Screening for Internalizing Antibodies by Homogeneous Fluorescence Imaging of a pH-Activated Probe". Journal of Biomolecular Screening 21, n.º 1 (30 de octubre de 2015): 12–23. http://dx.doi.org/10.1177/1087057115613270.
Texto completoPasswell, Justen H., Efrat Harlev, Shai Ashkenazi, Chiayung Chu, Dan Miron, Reut Ramon, Naheed Farzan et al. "Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel". Infection and Immunity 69, n.º 3 (1 de marzo de 2001): 1351–57. http://dx.doi.org/10.1128/iai.69.3.1351-1357.2001.
Texto completoPestka, James J. "Enhanced Surveillance of Foodborne Mycotoxins by Immunochemical Assay". Journal of AOAC INTERNATIONAL 71, n.º 6 (1 de noviembre de 1988): 1075–81. http://dx.doi.org/10.1093/jaoac/71.6.1075.
Texto completoNiculescu-Duvaz, I. y C. J. Springer. "Antibody-Directed Enzyme Prodrug Therapy (ADEPT): A Targeting Strategy in Cancer Chemotherapy". Current Medicinal Chemistry 2, n.º 3 (octubre de 1995): 687–706. http://dx.doi.org/10.2174/092986730203220223143057.
Texto completoLaske, Douglas W., Orhan Ilercil, Aytac Akbasak, Richard J. Youle y Edward H. Oldfield. "Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice". Journal of Neurosurgery 80, n.º 3 (marzo de 1994): 520–26. http://dx.doi.org/10.3171/jns.1994.80.3.0520.
Texto completoShi, Xiarong, Leiliane P. Sousa, Elizabeth M. Mandel-Bausch, Francisco Tome, Andrey V. Reshetnyak, Yaron Hadari, Joseph Schlessinger y Irit Lax. "Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition". Proceedings of the National Academy of Sciences 113, n.º 33 (1 de agosto de 2016): E4784—E4793. http://dx.doi.org/10.1073/pnas.1610179113.
Texto completoManiecki, Maciej Bogdan, Henrik Hasle, Knud Bendix y Holger Jon Møller. "Hepatotoxicity in Patients Treated with Gemtuzumab Ozogamicin - Specific Targeting of Hepatocytes?" Blood 114, n.º 22 (20 de noviembre de 2009): 4150. http://dx.doi.org/10.1182/blood.v114.22.4150.4150.
Texto completoValent, Peter, Irina Sadovnik, Gregor Eisenwort, Karin Bauer, Harald Herrmann, Karoline V. Gleixner, Axel Schulenburg, Werner Rabitsch, Wolfgang R. Sperr y Dominik Wolf. "Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML". International Journal of Molecular Sciences 20, n.º 17 (29 de agosto de 2019): 4233. http://dx.doi.org/10.3390/ijms20174233.
Texto completoBendell, Johanna C., Judy Sing-Zan Wang, Babar Bashir, Debra L. Richardson, Gavin Bennett, Carly Campbell, Meliessa G. Hennessy et al. "BT5528-100 phase I/II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients with advanced malignancies associated with EphA2 expression." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): TPS3655. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps3655.
Texto completoCabello-Alemán, Lucía. "Future directions in cancer immunotherapy with monoclonal antibodies". Research Results in Pharmacology 8, n.º 4 (15 de diciembre de 2022): 101–7. http://dx.doi.org/10.3897/rrpharmacology.8.85918.
Texto completoMahheidari, Naimeh, Jamal Rashidiani, Hamid Kooshki y Khadijeh Eskandari. "An Effort to Making a Colorimitric Nano-Biosensor for Vibrio cholera Detection". Current Nanoscience 16, n.º 5 (5 de octubre de 2020): 793–804. http://dx.doi.org/10.2174/1573413716666191230154316.
Texto completoAkter, Sultana, Teemu Kustila, Janne Leivo, Gangatharan Muralitharan, Markus Vehniäinen y Urpo Lamminmäki. "Noncompetitive Chromogenic Lateral-Flow Immunoassay for Simultaneous Detection of Microcystins and Nodularin". Biosensors 9, n.º 2 (18 de junio de 2019): 79. http://dx.doi.org/10.3390/bios9020079.
Texto completoWrobel, Charles J., Donald C. Wright, Robert L. Dedrick y Richard J. Youle. "Diphtheria toxin effects on brain-tumor xenografts". Journal of Neurosurgery 72, n.º 6 (junio de 1990): 946–50. http://dx.doi.org/10.3171/jns.1990.72.6.0946.
Texto completoBudde, Lihua Elizabeth, Armen Mardiros, Wen-Chung Chang, Xiuli Wang, Carolina Berger, Christine Brown, Stanley R. Riddell, Oliver W. Press y Stephen J. Forman. "Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy". Blood 122, n.º 21 (15 de noviembre de 2013): 1660. http://dx.doi.org/10.1182/blood.v122.21.1660.1660.
Texto completoEriksson, Kristina, Margareta Fredriksson, Inger Nordström y Jan Holmgren. "Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development". Infection and Immunity 71, n.º 4 (abril de 2003): 1740–47. http://dx.doi.org/10.1128/iai.71.4.1740-1747.2003.
Texto completo